VKTX – viking therapeutics, inc. (US:NASDAQ)

News

Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $102.00 price target on the stock.
Why Viking Therapeutics Inc. (VKTX) Went Down on Monday [Yahoo! Finance]
2 Stocks to Buy With Less Than $40 [Yahoo! Finance]
2 Stocks That Could Soar Again in 2025 [Yahoo! Finance]
Down 65%, Is Viking Therapeutics Stock a Buy on the Dip? [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com